During the past decade, Singapore National Eye Centre conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 6 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Singapore National Eye Centre" #1 sponsor was "Singapore National Eye Centre" with 39 trials, followed by "Singapore Eye Research Institute" with 6 trials sponsored, "Allergan" with 3 trials sponsored, "AcuFocus, Inc." with 2 trials sponsored and "Louis Tong" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Singapore National Eye Centre" #1 collaborator was "Singapore Eye Research Institute" with 9 trials as a collaborator, "National University Hospital, Singapore" with 3 trials as a collaborator, "National University of Singapore" with 3 trials as a collaborator, "National Medical Research Council (NMRC), Singapore" with 2 trials as a collaborator and "Singapore National Eye Centre" with 2 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Singapore National Eye Centre" are "Glaucoma" (10 trials), "Myopia" (6 trials), "Pterygium" (4 trials), "Keratoconus" (3 trials) and "Cataract" (2 trials). Many other conditions were trialed in "Singapore National Eye Centre" in a lesser frequency.

Most popular intervention types in "Singapore National Eye Centre" are "Drug" (19 trials), "Procedure" (15 trials), "Device" (13 trials), "Other" (5 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bimatoprost SR" (2 trials), "Selective Laser Trabeculoplasty" (2 trials), "(including placebo)" (1 trials), "0.1% Riboflavin ophthalmic solution (KXL System With vibeX Rapid)" (1 trials) and "2% guttae ganciclovir" (1 trials). Other intervention names were less common.

The vast majority of trials in "Singapore National Eye Centre" are 59 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Singapore National Eye Centre". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 40 completed trials in Singapore National Eye Centre, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Singapore National Eye Centre, 4 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 24 trials that are defined as “Not Applicable".